FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3/CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY

被引：0
|
作者：
VANHOUTEN, AA
HAAGEN, IA
CLARK, M
GEERARS, A
DELAU, W
BAST, EJEG
DEGAST, GC
机构：
[1] UNIV HOSP UTRECHT,DEPT HEMATOL,UTRECHT,NETHERLANDS
[2] UNIV HOSP UTRECHT,DEPT IMMUNOL,UTRECHT,NETHERLANDS
[3] UNIV CAMBRIDGE,DEPT PATHOL,CAMBRIDGE,CAMBS,ENGLAND
来源：
EXPERIMENTAL HEMATOLOGY | 1993年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1120 / 1120
页数：1
相关论文
共 50 条
  • [31] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Libert, Diane
    Yuan, Constance M.
    Masih, Katherine E.
    Galera, Pallavi
    Salem, Dalia
    Shalabi, Haneen
    Yates, Bonnie
    Delbrook, Cindy
    Shern, Jack F.
    Fry, Terry J.
    Khan, Javed
    Stetler-Stevenson, Maryalice
    Shah, Nirali N.
    LEUKEMIA, 2020, 34 (11) : 3064 - 3069
  • [32] Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy
    Diane Libert
    Constance M. Yuan
    Katherine E. Masih
    Pallavi Galera
    Dalia Salem
    Haneen Shalabi
    Bonnie Yates
    Cindy Delbrook
    Jack F. Shern
    Terry J. Fry
    Javed Khan
    Maryalice Stetler-Stevenson
    Nirali N. Shah
    Leukemia, 2020, 34 : 3064 - 3069
  • [33] A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib
    Mhibik, Maissa
    Gaglione, Erika M.
    Blackburn, Amy
    Keyvanfar, Keyvan
    Sun, Clare
    Ahn, Inhye E.
    Joao Baptista, Maria
    Qi, Junpeng
    Rader, Christoph
    Wiestner, Adrian
    BLOOD, 2019, 134
  • [34] CD3/CD19 depleted grafts for haploidentical stem cell transplantation in children: Results of a pilot study.
    Lang, Peter J.
    Mueller, Ingo
    Greill, Johann
    Bader, Peter
    Schumm, Michael
    Pfeiffer, Matthias
    Feuchtinger, Tobias
    Handgretinger, Rupert
    BLOOD, 2006, 108 (11) : 890A - 890A
  • [35] ATA3431: Allogeneic CD19/CD20 Bispecific CAR EBV T Cells for the Treatment of B-Cell Malignancies
    Cha, Seung
    Charbonneau, Morgan
    Brito, Alfonso
    Habibi, Ania
    Pham, Christina
    Nguyen, Cokey
    BLOOD, 2023, 142
  • [36] Bispecific targeting of CD20 and CD19 increases polyfunctionality of chimeric antigen receptor T-cell products in B-cell malignancies
    Zurko, Joanna C.
    Xu, Huiqing
    Chaney, Katherine
    Schneider, Dina
    Szabo, Aniko
    Hari, Parameswaran
    Johnson, Bryon D.
    Shah, Nirav N.
    CYTOTHERAPY, 2022, 24 (08) : 767 - 773
  • [37] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 930 - 930
  • [38] Immune reconstitution after haploidentical transplantation in children with hematological malignancies: a retrospective analysis using CD3/CD19 or TCRαβ/CD19 depleted mobilized peripheral stem cell grafts
    Diaz, M. A.
    Abad, L.
    Castillo, A.
    Perez, A.
    Deltoro, N.
    Gonzalez-Vicent, M.
    Ramirez, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S450 - S451
  • [39] Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Chen, Mingyi
    Koduru, Prasad
    Chen, Weina
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 (03) : 503 - 509
  • [40] Clinicopathologic Features of Relapsed CD19(-) B-ALL in CD19-Targeted Immunotherapy: Insights Into Mechanism of Relapse and LILRB1 as a Novel B-cell Marker for CD19(-) B Lymphoblasts
    Chen, Dong
    Fuda, Franklin
    Rosado, Flavia
    Saumell, Silvia
    John, Samuel
    Koduru, Prasad
    Chen, Weina
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 930 - 930
12345